Nuformix plc (LON:NFX)
London · Delayed Price · Currency is GBP · Price in GBX 0.1750
-0.0050 (-2.78%)
Jul 6, 2026, 4:03 PM GMT
Nuformix Market Cap
Nuformix has a market cap or net worth of 4.57 million as of July 6, 2026. Its market cap has increased by 161.54% in one year.
Market Cap
4.57M
Enterprise Value
3.64M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
0.18
Market Cap Chart
Since October 16, 2017, Nuformix's market cap has decreased from 17.28M to 4.57M, a decrease of -73.57%. That is a compound annual growth rate of -14.14%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 6, 2026 | 4.57M | -15.11% |
| Dec 31, 2025 | 5.38M | 698.00% |
| Dec 31, 2024 | 674.17K | -72.13% |
| Dec 29, 2023 | 2.42M | 0.30% |
| Dec 30, 2022 | 2.41M | -63.56% |
| Dec 31, 2021 | 6.62M | -52.25% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Oct 16, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Fusion Antibodies | 15.00M |
| Palatin Technologies | 14.43M |
| Genflow Biosciences | 11.61M |
| Cizzle Biotechnology Holdings | 10.62M |
| OptiBiotix Health | 6.66M |
| CRISM Therapeutics | 5.69M |
| Thalia Therapeutics | 5.41M |
| Oxford BioDynamics | 4.72M |